What causes Multiple Myeloma to recur

Multiple MyelomaMay 18, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Why Multiple Myeloma Comes Back: Understanding Recurrence

This is an important question, and understanding recurrence is key to your care planning. Let me explain what we know about why myeloma tends to come back.

The Fundamental Challenge: Cancer Cell Resistance

Multiple myeloma recurs because myeloma cells can develop resistance to treatment—meaning they learn to survive despite the medications designed to kill them. According to the NCCN Guidelines, this happens through several mechanisms:

1. Incomplete Elimination of Cancer Cells

Even when treatment appears successful and myeloma goes into remission (when signs and symptoms decrease or disappear), some myeloma cells may survive in your bone marrow. These surviving cells can be:

  • Too few to detect with current testing methods
  • Hidden in protected areas of the bone marrow
  • In a dormant or slow-growing state

Over time, these remaining cells can multiply again, causing a relapse (when symptoms return after a period of improvement).

2. Drug Resistance Development

The NCCN Guidelines emphasize that cancer can become resistant to a number of medications or even entire drug classes. This happens because:

  • Myeloma cells have genetic mutations that allow them to adapt
  • Cells that survive initial treatment may have genetic changes that protect them from that same drug
  • The surviving cells multiply, creating a population of treatment-resistant cancer

Think of it like bacteria developing antibiotic resistance—the cancer evolves to survive the treatment.

3. Genetic Instability of Myeloma Cells

According to the NCCN Guidelines, multiple myeloma often starts with genetic abnormalities (mutations) in plasma cells. These mutations don't stop after diagnosis. Myeloma cells continue to accumulate additional genetic changes over time, which can:

  • Make them more aggressive
  • Help them evade the immune system
  • Enable them to survive treatment

Why Recurrence Is Common

The NCCN Guidelines for Patients clearly state: "Most people with multiple myeloma can expect to have relapses." This isn't a failure of treatment—it's a characteristic of how myeloma behaves. The guidelines note that:

  • Myeloma is currently not curable, but it can be treated and controlled for significant periods
  • For many people, myeloma becomes a chronic condition they manage long-term rather than a disease they're cured of
  • New treatments have resulted in more long-term survivors than ever before

What Influences When Recurrence Happens

Several factors affect how quickly myeloma might return:

Genetic Risk Factors (found at diagnosis):

  • Certain chromosomal abnormalities are associated with higher risk of faster recurrence
  • For example, deletions of chromosome 17 or specific translocations (swapping of chromosome pieces) indicate more aggressive disease

Treatment Response:

  • How well your myeloma responded to initial treatment matters
  • Achieving deeper responses (like minimal residual disease negativity, meaning no detectable cancer cells) is associated with longer remission periods

Your Individual Biology:

  • How your specific myeloma cells mutate and adapt varies from person to person
  • Your overall health and ability to tolerate treatment affects options

The Important Reality

According to the NCCN Guidelines: "Sooner or later, myeloma usually comes back and requires additional treatment." However, this doesn't mean:

  • Your treatment failed
  • You're out of options
  • Your prognosis is poor

The guidelines emphasize that there are many different kinds of treatment for multiple myeloma, and if one therapy doesn't work or stops working, different treatments are available. In fact, the NCCN Guidelines note that after trying initial therapies, options like CAR T-cell therapy or bispecific antibody therapy become available for relapsed or resistant myeloma.

Questions to Ask Your Care Team

Understanding your specific situation is crucial:

  1. Based on my genetic testing and initial response, what's the expected timeline before my myeloma might return?
  2. What signs or symptoms should I watch for that might indicate recurrence?
  3. How will you monitor me to catch recurrence early?
  4. What are my treatment options if my myeloma comes back?
  5. Are there clinical trials available for relapsed myeloma that might be appropriate for me?

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: